Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 2

NCT07113964

QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficienc…

This study will evaluate the safety and efficacy of QL1706 and Olaparib in human epidermal growth factor receptor 2 (HER2)-negative unresectable and/or metastat…

China79 participantsStarted 2025-08-30

Treatment: QL1706 + olaparib